Suggestions
Alex Belser
Chief Clinical Officer, Cybin; Psychedelic Researcher; Psychologist
Professional Background
Dr. Alex Belser is a preeminent figure in the field of psychedelic medicine, serving as the Chief Clinical Officer at Cybin and as an investigator in groundbreaking psychedelic research trials at Yale University. With over 20 years of experience, Dr. Belser has played an influential role in the psychedelic clinical community, participating in numerous clinical trials investigating the efficacy of psilocybin and MDMA to treat various psychological conditions, including depression, anxiety, substance use disorders, obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), and end-of-life distress. His leadership extends beyond clinical practice; he is also the founding President of Nautilus Sanctuary, which holds the distinction of being the first non-profit center dedicated to psychedelic medicine on the east coast.
Dr. Belser's contributions to research and treatment methodologies have reverberated beyond the confines of clinical settings, gaining significant media attention. His research has been highlighted in notable publications like the New York Times, the Atlantic, the New Yorker, and The Guardian, as well as being featured in Michael Pollan's critically acclaimed book, "How to Change Your Mind," which explores the transformational potential of psychedelics. His involvement in clinical studies positions him at the forefront of examining the possibilities surrounding psychedelics as therapeutic agents.
Education and Achievements
Dr. Belser's extensive educational background underpins his expertise in mental health and psychedelic research. He is a distinguished alumnus of Georgetown University, where he earned a Bachelor of Arts degree in English and Government. He continued his academic pursuits at the University of Cambridge, where he completed an M.Phil. in Criminological Research. His academic journey took him to Columbia University, where he studied clinical psychology at Teachers College, before culminating in a Ph.D. in Counseling Psychology from New York University. Additionally, Dr. Belser has a Clinical Research Fellowship in Psychology at Yale University, signifying his commitment to melding academic inquiry with practical clinical applications.
Throughout his career, Dr. Belser has demonstrated an unwavering dedication to research, authoring over a dozen peer-reviewed journal articles and academic chapters. His insights into psychedelic medicine have established him as a thought leader in the sector, frequently sharing his knowledge through more than fifty lectures and presentations. His role at Yale involves exploring innovative psychedelic treatments specifically for OCD and depression, further reinforcing his ongoing commitment to advancing our understanding of these transformative substances.
Dr. Belser's previous roles highlight his strong leadership capabilities within the healthcare and psychedelic communities. He co-founded and directed clinical research at organizations such as Happy and served as a clinical research fellow at Yale. He has also been engaged in high-stakes clinical investigations, including his role as a study therapist for the MAPS MDMA-Psychotherapy Trial focused on severe PTSD treatment.
Community Involvement and Advocacy
Dr. Belser’s professional journey extends beyond research into community advocacy. He was previously a member of the Board of Advisors for Compass Pathways, a notable non-profit organization focusing on mental health treatment solutions. A passionate advocate for social justice, he is an active member of the Chacruna Institute’s Women, Gender Diversity, and Sexual Minorities Working Group. In this role, he addresses critical issues that affect LGBTQI+ individuals, striving for inclusivity and equitable access to psychedelic-assisted therapies, which speaks to his commitment to improving the mental health landscape for underserved communities.
Dr. Belser also brings a unique set of skills to his practice as a licensed kundalini and hatha yoga teacher, drawing from somatic practices to enhance therapeutic techniques in his clinical work. This holistic approach enriches his practice, fostering a deeper understanding of the intersection between mental health, mindfulness, and body awareness. His dedication to ongoing personal and professional development in these areas emphasizes the importance of integrating diverse modalities into patient care.
In summary, Dr. Alex Belser stands out as a leader in the field of psychedelic medicine, thanks to his extensive clinical experience, robust research background, and active participation in advocacy efforts for mental health. His contributions are shaping the future of psychedelic treatments, with implications that could profoundly impact countless lives. As he continues his journey, Dr. Belser remains committed to enhancing our understanding of psychedelics and their capacity to foster healing and transformation across diverse populations.
tags:[